Close Menu
April 16, 2021
Sponsored by
Thermo Fisher Scientific

The Post-Vaccine COVID Testing Landscape: A Virtual Roundtable Discussion

GenomeWebinar

Senior Scientific Director and Head of R&D, 
Quest Diagnostics Infectious Disease

Professor and Vice Chair, Pathology; Medical Director, Molecular Diagnostics
Froedtert Hospital & Medical College of Wisconsin

Professor of Practice, Arizona State University
Managing Director, BlueStone Venture Partners

Director, Infectious Disease, Association of Public Health Laboratories

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

When vaccines are broadly implemented and SARS-CoV-2 positivity rates are lower, pooled testing may become more widespread as a means to prevent future outbreaks. There may also be greater adoption of serology tests to monitor people who have been vaccinated, as well as the potential for more decentralized testing. Furthermore, clinical labs and test developers will need to adjust for increases in testing volumes for segments that were neglected during the pandemic.

This virtual roundtable discussion will assemble a panel of industry stakeholders, including clinical and public labs, to discuss how they are planning for a post-vaccine testing landscape.

The session will include a live Q&A in which attendees can post questions to our panelists.

Sponsored by

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.

Apr
15
Sponsored by
Combinati

Detection and quantification of SARS-CoV-2 levels in wastewater can be a useful predictor of potential COVID-19 outbreaks. However, the interpretation of the surveillance data can be challenging.

Apr
16
Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

Apr
22
Sponsored by
10x Genomics

The human immune system is extremely complex, comprised of multiple cell types and states interacting in myriad ways to produce diverse cellular ecosystems.

Apr
23
Sponsored by
Isoplexis

Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function.